CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
NASDAQ · Healthcare · Medical - Healthcare Plans · US
$4.46
−1.76%Next report
Analyst consensus
- Next report date
- Nov 3, 2026
- EPS estimate
- -$0.01
- Revenue estimate
- $740.3M
Latest reported
- Last report date
- Aug 5, 2026
- EPS actual
- $0.05
- EPS estimate
- $0.04
- Revenue actual
- $743.2M
- Revenue estimate
- $728.3M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -69.4%
- Revenue beats (12Q)
- 6
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $5.25
- PT range
- $5.00 – $5.50
- Analysts
- 2
1 Buy1 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 5, 2026 | $0.04 | $0.05 | Beat 29.40% | $743.2M |
| May 6, 2026 | $0.07 | $0.07 | In line | $749.2M |
| Nov 4, 2025 | $0.02 | -$0.05 | Miss -350.00% | $496.6M |
| Mar 11, 2025 | -$0.07 | -$0.04 | Beat 42.86% | $337.0M |
| Mar 12, 2024 | -$0.18 | -$0.12 | Beat 33.33% | $510.3M |
| Feb 28, 2023 | -$0.34 | -$0.23 | Beat 32.35% | $898.8M |
| Feb 28, 2022 | -$0.26 | -$0.44 | Miss -69.23% | $432.0M |
| Aug 11, 2021 | -$0.17 | -$0.45 | Miss -164.71% | $412.5M |
| May 17, 2021 | -$0.12 | -$0.13 | Miss -8.33% | $200.3M |
| Mar 1, 2021 | -$0.84 | $0.01 | Beat 100.96% | $506.7M |
| Aug 13, 2020 | — | $0.01 | — | $172.1M |
| Jun 4, 2020 | — | -$0.07 | — | $165.5M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 3, 2026